Quaker Chemical Swings to Loss on Impairment Charges, Sales Up

TL;DR

**KWR's Q3 is a red flag: sales up, but massive impairment charges and restructuring costs signal deep underlying issues, making it a risky bet.**

AI Summary

Quaker Chemical Corp (KWR) reported a mixed financial performance for the nine months ended September 30, 2025. While net sales increased to $1,420.156 million, up from $1,395.600 million in the prior year, the company experienced a significant net loss of $23.160 million, a sharp decline from a net income of $102.540 million in the same period of 2024. This loss was primarily driven by substantial impairment charges of $88.840 million and increased restructuring and related charges of $31.128 million, compared to zero and $4.787 million respectively in the prior year. Operating income plummeted to $21.755 million from $165.693 million. The company completed two key acquisitions in April 2025: Dipsol Chemicals Co., Ltd. for approximately $185.6 million and Natech, Ltd. for $6.5 million, funded by existing credit facilities. These acquisitions contributed $41.5 million to net sales for the nine-month period. Diluted EPS fell to -$1.32 from $5.70, while dividends declared increased to $1.478 per share from $1.395.

Why It Matters

This filing reveals a concerning shift for Quaker Chemical, as a substantial net loss of $23.160 million, primarily due to $88.840 million in impairment charges, overshadows modest sales growth. For investors, this indicates potential asset write-downs or underperforming segments, raising questions about future profitability and asset valuation. Employees might face uncertainty given the significant restructuring charges of $31.128 million. Customers could see benefits from the Dipsol and Natech acquisitions, which expand KWR's advanced solutions and surface treatment offerings, potentially enhancing competitive positioning against rivals like Fuchs Petrolub. However, the overall financial strain could limit further R&D or service improvements, impacting market share in the long run.

Risk Assessment

Risk Level: high — The risk level is high due to a significant net loss of $23.160 million for the nine months ended September 30, 2025, compared to a net income of $102.540 million in the prior year. This reversal is largely attributable to $88.840 million in impairment charges and a substantial increase in restructuring charges to $31.128 million from $4.787 million, indicating potential operational inefficiencies or asset devaluation.

Analyst Insight

Investors should scrutinize the nature of the $88.840 million impairment charges and the $31.128 million restructuring costs to understand if these are one-time events or indicative of deeper, systemic issues. Consider holding off on new investments until management provides clearer guidance on how these significant charges will impact future earnings and if the recent acquisitions of Dipsol and Natech can sufficiently offset these headwinds.

Financial Highlights

revenue

$1,420.156M

operating Margin

1.53%

net Income

-$23.160M

eps

-$1.32

gross Margin

36.18%

revenue Growth

+1.75%

Key Numbers

• $1,420.156M — Net Sales (Increased from $1,395.600M in 2024 for nine months)
• -$23.160M — Net Income (Loss) (Significant decline from $102.540M net income in 2024 for nine months)
• $88.840M — Impairment Charges (New charge in 2025, zero in 2024, contributing to net loss)
• $31.128M — Restructuring Charges (Increased from $4.787M in 2024 for nine months)
• $21.755M — Operating Income (Fell sharply from $165.693M in 2024 for nine months)
• -$1.32 — Diluted EPS (Decreased from $5.70 in 2024 for nine months)
• $1.478 — Dividends Declared per Share (Increased from $1.395 in 2024 for nine months)
• $185.6M — Dipsol Acquisition Price (Funded by existing credit facility in April 2025)
• $6.5M — Natech Acquisition Price (Acquired in April 2025)
• $41.5M — Acquisition Sales Contribution (Sales from Dipsol and Natech for nine months ended Sept 30, 2025)

Key Players & Entities

• QUAKER CHEMICAL CORP (company) — registrant
• Dipsol Chemicals Co., Ltd. (company) — acquired company
• Natech, Ltd. (company) — acquired company
• SEC (regulator) — Securities and Exchange Commission
• $185.6 million (dollar_amount) — Dipsol acquisition price
• $6.5 million (dollar_amount) — Natech acquisition price
• $23.160 million (dollar_amount) — Net loss for nine months ended Sept 30, 2025
• $88.840 million (dollar_amount) — Impairment charges for nine months ended Sept 30, 2025
• $31.128 million (dollar_amount) — Restructuring and related charges for nine months ended Sept 30, 2025
• New York Stock Exchange (regulator) — exchange where KWR is registered

FAQ

Risk Factors

• Impairment and Restructuring Charges [high — operational]: The company incurred significant impairment charges of $88.840 million and increased restructuring and related charges of $31.128 million for the nine months ended September 30, 2025. These charges, which were $0 and $4.787 million respectively in the prior year, severely impacted operating income and led to a net loss.
• Acquisition Integration and Funding [medium — financial]: Quaker Chemical completed two acquisitions in April 2025, Dipsol Chemicals for $185.6 million and Natech for $6.5 million, funded by existing credit facilities. While these contributed $41.5 million in sales, the integration and ongoing costs, along with the debt used for funding, pose financial risks.
• Sales Growth Slowdown [medium — market]: Net sales increased only slightly to $1,420.156 million for the nine months ended September 30, 2025, up from $1,395.600 million in the prior year. This represents a growth of approximately 1.75%, indicating a slowdown in top-line expansion, especially considering the contribution from recent acquisitions.

Industry Context

The specialty chemicals industry, where Quaker Chemical operates, is characterized by a focus on performance-driven products and solutions for diverse end markets. Key trends include sustainability, digitalization, and consolidation through M&A. Companies like KWR compete on innovation, technical service, and global reach.

Regulatory Implications

As a global chemical manufacturer, Quaker Chemical is subject to various environmental, health, and safety regulations in the jurisdictions where it operates. Compliance with these regulations, including chemical registration and handling standards, is crucial to avoid penalties and maintain operational continuity.

What Investors Should Do

1. Monitor acquisition integration and performance
2. Analyze the drivers of impairment and restructuring charges
3. Evaluate debt levels and credit facility usage
4. Assess operating margin trends

Key Dates

• 2025-04-XX: Acquisition of Dipsol Chemicals and Natech — These acquisitions, costing $185.6 million and $6.5 million respectively, were funded by credit facilities and are expected to contribute to future growth, though they also introduce integration risks and increased debt.
• 2025-09-30: Nine Months Ended Financial Reporting — This period revealed a significant net loss of $23.160 million, driven by substantial impairment and restructuring charges, a stark contrast to the prior year's profitability.
• 2024-09-30: Nine Months Ended Financial Reporting — The company reported a strong net income of $102.540 million and operating income of $165.693 million, highlighting the significant downturn in the current year's performance.

Glossary

Impairment charges

A reduction in the carrying value of an asset on the balance sheet when its fair value falls below its book value. (These charges of $88.840 million significantly contributed to Quaker Chemical's net loss in the nine months ended September 30, 2025.)

Restructuring and related charges, net

Costs associated with significant reorganizations, such as layoffs, facility closures, or business divestitures. (An increase in these charges to $31.128 million in 2025, compared to $4.787 million in 2024, further impacted the company's profitability.)

Diluted EPS

Earnings per share calculated by dividing net income by the total number of diluted shares outstanding, including all convertible securities, options, and warrants. (Diluted EPS fell sharply to -$1.32 from $5.70, reflecting the substantial net loss incurred by the company.)

Noncontrolling interest

The portion of equity in a subsidiary that is not attributable to the parent company. (Net income attributable to noncontrolling interest was minimal ($29 thousand for nine months ended Sept 30, 2025), indicating that the majority of the consolidated results belong to Quaker Chemical Corporation.)

Year-Over-Year Comparison

Compared to the nine months ended September 30, 2024, Quaker Chemical Corp. has seen a modest increase in net sales from $1,395.600 million to $1,420.156 million. However, profitability has drastically deteriorated, with net income plummeting from $102.540 million to a net loss of $23.160 million. This reversal is primarily due to significant impairment charges of $88.840 million and higher restructuring costs, leading to a sharp decline in operating income and diluted EPS.

Key Financial Figures

• $1 — ange on which registered Common Stock, $1 par value KWR New York Stock Exchange

Filing Documents

• kwr-20250930.htm (10-Q) — 1637KB
• ex101stevendassingemployme.htm (EX-10.1) — 66KB
• kwr2025q3-exx311.htm (EX-31.1) — 10KB
• kwr2025q3-exx312.htm (EX-31.2) — 10KB
• kwr2025q3-exx321.htm (EX-32.1) — 3KB
• kwr2025q3-exx322.htm (EX-32.2) — 3KB
• image_0.jpg (GRAPHIC) — 62KB
• 0001628280-25-047572.txt ( ) — 9521KB
• kwr-20250930.xsd (EX-101.SCH) — 50KB
• kwr-20250930_cal.xml (EX-101.CAL) — 104KB
• kwr-20250930_def.xml (EX-101.DEF) — 269KB
• kwr-20250930_lab.xml (EX-101.LAB) — 697KB
• kwr-20250930_pre.xml (EX-101.PRE) — 521KB
• kwr-20250930_htm.xml (XML) — 1555KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 2 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and September 30, 2024 2 Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2025 and September 30, 2024 3 Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 4 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and September 30, 2024 5 Condensed Consolidated Statements of Changes in Equity for the Three and Nine Months Ended September 30, 2025 and September 30, 2024 6 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 28 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk. 42 Item 4.

Controls and Procedures

Controls and Procedures. 42 PART II OTHER INFORMATION. Item 1. Legal Proceedings. 43 Item 1A. Risk Factors. 43 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 43

Other Information

Item 5. Other Information. 43 Item 6. Exhibits. 44 Signatures . 45 1 Table of Contents PART I FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited). Quaker Chemical Corporation Condensed Consolidated Statements of Operations (Unaudited; Dollars in thousands, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net sales $ 493,842 $ 462,274 $ 1,420,156 $ 1,395,600 Cost of goods sold (excluding amortization expense - See Note 13) 312,977 289,725 906,308 865,770 Gross profit 180,865 172,549 513,848 529,830 Selling, general and administrative expenses 126,479 118,221 372,125 359,350 Impairment charges — — 88,840 — Restructuring and related charges, net 7,745 2,610 31,128 4,787 Operating income 46,641 51,718 21,755 165,693 Other (expense) income, net ( 270 ) 783 ( 1,632 ) 2,285 Interest expense ( 10,941 ) ( 10,347 ) ( 33,265 ) ( 31,925 ) Income (loss) before taxes and equity in net income of associated companies 35,430 42,154 ( 13,142 ) 136,053 Taxes on income before equity in net income of associated companies 9,266 12,167 22,280 40,453 Income (loss) before equity in net income of associated companies 26,164 29,987 ( 35,422 ) 95,600 Equity in net income of associated companies 4,322 2,385 12,262 6,940 Net income (loss) 30,486 32,372 ( 23,160 ) 102,540 Less: Net income attributable to noncontrolling interest 17 26 29 82 Net income (loss) attributable to Quaker Chemical Corporation $ 30,469 $ 32,346 $ ( 23,189 ) $ 102,458 Per share data: Net income (loss) attributable to Quaker Chemical Corporation common shareholders – basic $ 1.75 $ 1.81 $ ( 1.32 ) $ 5.71 Net income (loss) attributable to Quaker Chemical Corporation common shareholders – diluted $ 1.75 $ 1.81 $ ( 1.32 ) $ 5.70 Dividends declared $ 0.508 $ 0.485 $ 1.478 $ 1.395 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 2 Table of Content Quaker Chemical Corporation Condensed Consolidated Statements of Comprehensive Income (Unaudited; Dollars in thousands) Three Months En

View Full Filing

View this 10-Q filing on SEC EDGAR